Immucor Revenue and Competitors
Estimated Revenue & Valuation
- Immucor's estimated annual revenue is currently $602.4M per year.
- Immucor's estimated revenue per employee is $251,000
Employee Data
- Immucor has 2400 Employees.
Immucor Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $28.5M | 153 | 1% | N/A | N/A |
What Is Immucor?
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.
keywords:N/AN/A
Total Funding
2400
Number of Employees
$602.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immucor's People
Name | Title | Email/Phone |
---|---|---|
1 | Manager Helpdesk Support | Reveal Email/Phone |
2 | Human Resources Business Partner | Reveal Email/Phone |
3 | Senior Director, Quality Systems and Field Quality | Reveal Email/Phone |
4 | VP & General Counsel | Reveal Email/Phone |
5 | Commercial Training Manager | Reveal Email/Phone |
6 | System Engineer | Reveal Email/Phone |
7 | Director Product Support | Reveal Email/Phone |
8 | Manager, Quality Operations - Post Market Surveillance | Reveal Email/Phone |
9 | Global Support Engineer | Reveal Email/Phone |
10 | Scientist I | Reveal Email/Phone |
Immucor News
... Scope And Outlook | Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-LA Roche, Ltd., Illumina, Inc., Immucor, Inc.
Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostic, BD, Beckman Coulter, DIAGAST, Hemo bioscience,...
Carlyle Group, Immucor, Illumina, Siemens Healthineers, Agilent Technologies. This comprehensive Transplant Diagnostic Market report helps...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1840.1M | 4005 | 6% | N/A |
#2 | $3405M | 5153 | 2% | N/A |
#3 | $2296M | 5525 | 8% | N/A |
#4 | $1070M | 7947 | 4% | N/A |
#5 | $5309.2M | 20548 | 6% | N/A |